Automated quantitative analysis of hepatitis B virus DNA by using the Cobas Amplicor HBV Monitor test

Journal of Clinical Microbiology

Volumn 37, Issue 9, 1999, Pages 2793-2797

  Noborg, Ulrika ^a   Gusdal, Annkatrin ^a   Pisa, Eva K ^b   Hedrum, Anders ^b   Lindh, Magnus ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b AB Sangtec Medical   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ANTIBODY TITER; ARTICLE; AUTOMATION; DIAGNOSTIC ACCURACY; DNA DETERMINATION; GENE AMPLIFICATION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ASSAY; REPRODUCIBILITY; VIRUS DETECTION;

EID: 0032807888     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.37.9.2793-2797.1999     Document Type: Article

References (14)

1. Allen, M. I., M. Deslauriers, C. W. Andrews, G. A. Tipples, K. A. Walters, D. L. Tyrrell, N. Brown, and L. D. Condreay. 1998. Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Lamivudine Clinical Investigation Group. Hepatology 27:1670-1677.
2. Berger, A., J. Braner, H. W. Doerr, and B. Weber. 1998. Quantification of viral load: clinical relevance for human immunodeficiency virus, hepatitis B virus and hepatitis C virus infection. Intervirology 41:24-34.
3. Chayama, K., Y. Suzuki, M. Kobayashi, M. Kobayashi, A. Tsubota, M. Hashimoto, Y. Miyano, H. Koike, M. Kobayashi, I. Koida, Y. Arase, S. Saltoh, N. Murashima, K. Ikeda, and H. Kumada. 1998. Emergence and takeover of YMDD motif mutant hepatitis B virus during long-term lamivudine therapy and re-takeover by wild type after cessation of therapy. Hepatology 27:1711-1716.
4. DiDomenico, N., H. Link, R. Knobel, T. Caratsch, W. Weschler, Z. Loewy, and M. Rosenstraus. 1996. COBAS AMPLICOR™: fully automated RNA and DNA amplification and detection system for routing diagnostic PCR. Clin. Chem. 42:1915-1923.
5. Erhardt, A., S. Schaefer, N. Athanassiou, M. Kann, and W. H. Gerlich. 1996. Quantitative assay of PCR-amplified hepatitis B virus DNA using a peroxidase-labelled DNA probe and enhanced chemiluminescence. J. Clin. Microbiol. 34:1885-1891.
6. Jardi, R., M. Buti, F. Rodriguez-Frias, M. Cortina, R. Esteban, J. Guardia, and C. Pascual. 1996. The value of quantitative detection of HBV-DNA amplified by PCR in the study of hepatitis B infection. J. Hepatol. 24:680-685.
7. Kessler, H. H., K. Pierer, E. Dragon, H. Lackner, B. Santner, D. Stunzner, E. Stelzl, B. Waltz, and E. Marth. 1998. Evaluation of a new assay for HBV DNA quantitation in patients with chronic hepatitis B. Clin. Diagn. Virol. 9:37-13.
8. Lai, C. L., R. N. Chien, N. W. Leung, T. T. Chang, R. Guan, D. I. Tai, K. Y. Ng, P. C. Wu, J. C. Dent, J. Barber, S. L. Stephenson, and D. F. Gray. 1998. A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group. N. Engl. J. Med. 339:61-68.
9. Lehtovaara, P., M. Uusi-Oukari, M. Laaksonen, M. Bengtström, and M. Ranki. 1993. Quantitative PCR for hepatitis B virus with colorimetric detection. PCR Methods Appl. 3:169-175.
10. Lindh, M., A. S. Andersson, and A. Gusdal. 1997. Genotypes, nt 1858 variants and geographic origin of hepatitis B virus - large-scale analysis using a new genotyping method. J. Infect. Dis. 175:1285-1293.
11. Lindh, M., J. E. Gonzalez, G. Norkrans, and P. Horal. 1998. Genotyping of hepatitis B virus by restriction pattern analysis of a pre-S amplicon. J. Virol. Methods 72:163-174.
12. Melegari, M., P. P. Scaglioni, and J. R. Wands. 1998. Hepatitis B virus mutants associated with 3TC and famciclovir administration are replication defective. Hepatology 27:628-633.
13. Niitsuma, H., M. Ishii, M. Miura, K. Kobayashi, and T. Toyota. 1997. Low level hepatitis B viremia detected by polymerase chain reaction accompanies the absence of HBe antigenemia and hepatitis in hepatitis B virus carriers. Am. J. Gastroenterol. 92:119-123.
14. Ranki, M., H. M. Schatzl, R. Zachoval, O. M. Uusi, and P. Lehtovaara. 1995. Quantification of hepatitis B virus DNA over a wide range from serum for studying viral replicative activity in response to treatment and in recurrent infection. Hepatology 21:1492-1499.